We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$329B
AUM Growth
+$18.7B
Cap. Flow
+$4.79B
Cap. Flow %
1.46%
Top 10 Hldgs %
17.35%
Holding
3,654
New
108
Increased
2,088
Reduced
988
Closed
104

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.91B
2
UPS icon
United Parcel Service
UPS
+$1.86B
3
CVX icon
Chevron
CVX
+$1.72B
4
BX icon
Blackstone
BX
+$904M
5
F icon
Ford
F
+$722M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.64B
2
PRU icon
Prudential Financial
PRU
+$553M
3
GPC icon
Genuine Parts
GPC
+$543M
4
CMI icon
Cummins
CMI
+$538M
5
HIG icon
Hartford Financial Services
HIG
+$376M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Healthcare 13.03%
3 Financials 11.86%
4 Consumer Discretionary 9.84%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
3401
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$37.2K ﹤0.01%
752
WRAP icon
3402
Wrap Technologies
WRAP
$103M
$37K ﹤0.01%
+21,515
New +$44.6K
UAVS icon
3403
AgEagle Aerial Systems
UAVS
$40.9M
$36.9K ﹤0.01%
+82
New +$36.2K
XFOR icon
3404
X4 Pharmaceuticals
XFOR
$375M
$36.9K ﹤0.01%
1,413
MTNB icon
3405
Matinas BioPharma
MTNB
$1.88M
$36.8K ﹤0.01%
1,568
GALT icon
3406
Galectin Therapeutics
GALT
$196M
$36.6K ﹤0.01%
17,413
SFR
3407
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
$36.5K ﹤0.01%
+64,067
New +$91.4K
XBIT icon
3408
XBiotech
XBIT
$68M
$36.1K ﹤0.01%
10,477
FATH
3409
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$36.1K ﹤0.01%
3,327
+2,218
+200% +$51.8K
APYX icon
3410
Apyx Medical
APYX
$173M
$36K ﹤0.01%
12,488
BMTX
3411
DELISTED
BM Technologies, Inc.
BMTX
$35.9K ﹤0.01%
10,210
AUD
3412
DELISTED
Audacy, Inc.
AUD
$35.9K ﹤0.01%
266,264
-4,326,838
-94% -$995K
CCLD icon
3413
CareCloud
CCLD
$104M
$35.7K ﹤0.01%
+10,649
New +$37.2K
VSTM icon
3414
Verastem
VSTM
$510M
$35.7K ﹤0.01%
7,159
AUGX
3415
DELISTED
Augmedix, Inc. Common Stock
AUGX
$35.7K ﹤0.01%
+20,489
New +$33.4K
SNCR
3416
DELISTED
Synchronoss Technologies
SNCR
$35.6K ﹤0.01%
4,207
ELDN icon
3417
Eledon Pharmaceuticals
ELDN
$261M
$35.4K ﹤0.01%
+14,987
New +$40.2K
KLR
3418
DELISTED
Kaleyra, Inc.
KLR
$35.1K ﹤0.01%
21,252
PVLA
3419
Palvella Therapeutics
PVLA
$1.99B
$34.9K ﹤0.01%
447
OESX icon
3420
Orion Energy Systems
OESX
$41M
$34.5K ﹤0.01%
1,699
LFMD icon
3421
LifeMD
LFMD
$169M
$34.4K ﹤0.01%
20,209
BOLT icon
3422
Bolt Biotherapeutics
BOLT
$7.67M
$34.4K ﹤0.01%
+1,236
New +$36.2K
PFIE
3423
DELISTED
Profire Energy, Inc
PFIE
$34.3K ﹤0.01%
+27,669
New +$32K
VHC icon
3424
VirnetX Holding Corp
VHC
$54.4M
$34.2K ﹤0.01%
1,305
CDTX
3425
DELISTED
Cidara Therapeutics
CDTX
$34.1K ﹤0.01%
+1,341
New +$38.1K

Similar funds

Charles Schwab's Q1 2023 Portfolio in Review

As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
  • Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
  • Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
  • Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
  • Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
  • Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
  • Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.